Related Experiment Video
Updated: Mar 18, 2026

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
Published on: June 2, 2019
PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious
Rona M Barron1, Declan King2, Martin Jeffrey3
1The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, Scotland, UK. rona.barron@roslin.ed.ac.uk.
Abstract:
Mammalian prions are unusual infectious agents, as they are thought to consist solely of aggregates of misfolded prion protein (PrP). Generation of synthetic prions, composed of recombinant PrP (recPrP) refolded into fibrils, has been utilised to address whether PrP aggregates are, indeed, infectious prions. In several reports, neurological disease similar to transmissible spongiform encephalopathy (TSE) has been described following inoculation and passage of various forms of fibrils in transgenic mice and hamsters. However, in studies described here, we show that inoculation of recPrP fibrils does not cause TSE disease, but, instead, seeds the formation of PrP amyloid plaques in PrP-P101L knock-in transgenic mice (101LL). Importantly, both WT-recPrP fibrils and 101L-recPrP fibrils can seed plaque formation, indicating that the fibrillar conformation, and not the primary sequence of PrP in the inoculum, is important in initiating seeding. No replication of infectious prions or TSE disease was observed following both primary inoculation and subsequent subpassage. These data, therefore, argue against recPrP fibrils being infectious prions and, instead, indicate that these pre-formed seeds are acting to accelerate the formation of PrP amyloid plaques in 101LL Tg mice. In addition, these data reproduce a phenotype which was previously observed in 101LL mice following inoculation with brain extract containing in vivo-generated PrP amyloid fibrils, which has not been shown for other synthetic prion models. These data are reminiscent of the "prion-like" spread of aggregated forms of the beta-amyloid peptide (Aβ), α-synuclein and tau observed following inoculation of transgenic mice with pre-formed seeds of each misfolded protein. Hence, even when the protein is PrP, misfolding and aggregation do not reproduce the full clinicopathological phenotype of disease. The initiation and spread of protein aggregation in transgenic mouse lines following inoculation with pre-formed fibrils may, therefore, more closely resemble a seeded proteinopathy than an infectious TSE disease.
Insights
Synthetic prion protein (recPrP) fibrils do not cause transmissible spongiform encephalopathy (TSE) disease. Instead, these fibrils seed amyloid plaque formation in mice, suggesting a prion-like proteinopathy rather than infectious TSE.
Area of Science:
- Neuroscience
- Biochemistry
- Protein Misfolding Diseases
Background:
- Mammalian prions are infectious agents composed of misfolded prion protein (PrP).
- Synthetic prions, made from recombinant PrP (recPrP) fibrils, have been used to investigate PrP's role in disease.
- Previous studies suggested synthetic prions could cause transmissible spongiform encephalopathy (TSE) in animal models.
Purpose of the Study:
- To determine if recombinant PrP (recPrP) fibrils constitute infectious prions.
- To investigate the mechanism by which synthetic PrP aggregates interact with host PrP.
- To compare the effects of synthetic PrP fibrils with naturally occurring prion diseases.
Main Methods:
- Inoculation of wild-type and mutant recPrP fibrils into PrP-P101L knock-in transgenic mice (101LL).
- Observation for clinical signs of TSE disease and neuropathological examination.
- Assessment of PrP amyloid plaque formation and prion replication following primary and secondary inoculation.
Main Results:
- Inoculation with recPrP fibrils did not induce TSE disease or prion replication.
- Both wild-type and mutant recPrP fibrils successfully seeded PrP amyloid plaque formation in 101LL mice.
- The fibrillar conformation, not the primary sequence, was critical for initiating seeding, mimicking a seeded proteinopathy.
Conclusions:
- RecPrP fibrils are not infectious prions but act as seeds to accelerate amyloid plaque formation.
- The observed phenotype resembles seeded proteinopathies (e.g., Alzheimer's, Parkinson's) more than infectious TSE.
- Misfolding and aggregation of PrP alone do not fully replicate the clinicopathological features of infectious prion diseases.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils

